Russell Lonser

Dr. Lonser’s laboratory and translational research interests include development of direct nervous system drug delivery paradigms for targeted therapy, as well as investigation of tumor pathogenesis and biology in familial neoplasia syndromes. Specifically, his investigation is directed toward developing convective delivery strategies to treat central nervous system pathobiology, and toward neoplasia pathogenesis/propagation in familial tumor-suppressor syndromes, including von Hippel-Lindau disease. His clinical and surgical research interests are centered on the treatment of primary brain, brainstem and spinal cord tumors.